nodes	percent_of_prediction	percent_of_DWPC	metapath
Liotrix—ABCB1—esophageal cancer	0.203	1	CbGaD
Liotrix—SLCO4C1—Methotrexate—esophageal cancer	0.179	0.326	CbGbCtD
Liotrix—SLCO1C1—Methotrexate—esophageal cancer	0.126	0.229	CbGbCtD
Liotrix—SLCO1B3—Methotrexate—esophageal cancer	0.0703	0.128	CbGbCtD
Liotrix—SLCO1A2—Methotrexate—esophageal cancer	0.0434	0.0789	CbGbCtD
Liotrix—SLCO1B1—Methotrexate—esophageal cancer	0.0409	0.0745	CbGbCtD
Liotrix—SLC22A8—Methotrexate—esophageal cancer	0.0378	0.0687	CbGbCtD
Liotrix—ALB—Methotrexate—esophageal cancer	0.0224	0.0408	CbGbCtD
Liotrix—ABCB1—Cisplatin—esophageal cancer	0.0181	0.0329	CbGbCtD
Liotrix—ABCB1—Methotrexate—esophageal cancer	0.0117	0.0213	CbGbCtD
Liotrix—Venous thrombosis—Carboplatin—esophageal cancer	0.0056	0.0573	CcSEcCtD
Liotrix—SERPINA7—neck—esophageal cancer	0.00559	0.106	CbGeAlD
Liotrix—Fluid overload—Carboplatin—esophageal cancer	0.00486	0.0497	CcSEcCtD
Liotrix—Temperature intolerance—Capecitabine—esophageal cancer	0.00398	0.0407	CcSEcCtD
Liotrix—Extravasation—Carboplatin—esophageal cancer	0.00346	0.0354	CcSEcCtD
Liotrix—THRB—neck—esophageal cancer	0.00345	0.0656	CbGeAlD
Liotrix—THRA—neck—esophageal cancer	0.00345	0.0656	CbGeAlD
Liotrix—SLC16A2—neck—esophageal cancer	0.00313	0.0594	CbGeAlD
Liotrix—Bronchopneumonia—Capecitabine—esophageal cancer	0.00299	0.0306	CcSEcCtD
Liotrix—Tetany—Cisplatin—esophageal cancer	0.00272	0.0278	CcSEcCtD
Liotrix—TTR—neck—esophageal cancer	0.00257	0.0488	CbGeAlD
Liotrix—Phlebitis—Carboplatin—esophageal cancer	0.00255	0.0261	CcSEcCtD
Liotrix—SLCO4C1—trachea—esophageal cancer	0.00217	0.0412	CbGeAlD
Liotrix—SLC16A10—neck—esophageal cancer	0.00202	0.0383	CbGeAlD
Liotrix—SLC16A2—trachea—esophageal cancer	0.00188	0.0358	CbGeAlD
Liotrix—Infertility—Methotrexate—esophageal cancer	0.00186	0.0191	CcSEcCtD
Liotrix—Venous thrombosis—Cisplatin—esophageal cancer	0.00164	0.0168	CcSEcCtD
Liotrix—SLC10A1—digestive system—esophageal cancer	0.00158	0.03	CbGeAlD
Liotrix—SLCO4C1—lung—esophageal cancer	0.00156	0.0296	CbGeAlD
Liotrix—SLCO4A1—bronchus—esophageal cancer	0.00154	0.0293	CbGeAlD
Liotrix—SLCO1B3—lung—esophageal cancer	0.00151	0.0288	CbGeAlD
Liotrix—THRB—lung—esophageal cancer	0.00149	0.0284	CbGeAlD
Liotrix—THRA—lung—esophageal cancer	0.00149	0.0284	CbGeAlD
Liotrix—Fluid overload—Cisplatin—esophageal cancer	0.00143	0.0146	CcSEcCtD
Liotrix—SLCO4A1—trachea—esophageal cancer	0.00138	0.0263	CbGeAlD
Liotrix—SLC16A10—epithelium—esophageal cancer	0.00137	0.0261	CbGeAlD
Liotrix—Swelling face—Capecitabine—esophageal cancer	0.00137	0.014	CcSEcCtD
Liotrix—SLC16A2—lung—esophageal cancer	0.00135	0.0257	CbGeAlD
Liotrix—TTR—digestive system—esophageal cancer	0.00133	0.0252	CbGeAlD
Liotrix—Intestinal perforation—Methotrexate—esophageal cancer	0.00123	0.0126	CcSEcCtD
Liotrix—Venous thrombosis—Capecitabine—esophageal cancer	0.00121	0.0124	CcSEcCtD
Liotrix—SLCO4A1—digestive system—esophageal cancer	0.00119	0.0226	CbGeAlD
Liotrix—Necrosis—Cisplatin—esophageal cancer	0.00113	0.0116	CcSEcCtD
Liotrix—Abscess—Cisplatin—esophageal cancer	0.00112	0.0115	CcSEcCtD
Liotrix—TTR—lung—esophageal cancer	0.00111	0.0211	CbGeAlD
Liotrix—Infection—Carboplatin—esophageal cancer	0.00107	0.011	CcSEcCtD
Liotrix—SLCO1B1—digestive system—esophageal cancer	0.00105	0.0199	CbGeAlD
Liotrix—THRB—lymph node—esophageal cancer	0.00102	0.0194	CbGeAlD
Liotrix—THRA—lymph node—esophageal cancer	0.00102	0.0194	CbGeAlD
Liotrix—Extravasation—Cisplatin—esophageal cancer	0.00102	0.0104	CcSEcCtD
Liotrix—Tenderness—Cisplatin—esophageal cancer	0.00102	0.0104	CcSEcCtD
Liotrix—SLCO4A1—lung—esophageal cancer	0.000995	0.0189	CbGeAlD
Liotrix—Cellulitis—Cisplatin—esophageal cancer	0.000975	0.00998	CcSEcCtD
Liotrix—Intestinal obstruction—Capecitabine—esophageal cancer	0.000959	0.00981	CcSEcCtD
Liotrix—Ulcer—Cisplatin—esophageal cancer	0.000937	0.00959	CcSEcCtD
Liotrix—SLC16A2—lymph node—esophageal cancer	0.000925	0.0176	CbGeAlD
Liotrix—SLC16A10—lung—esophageal cancer	0.000872	0.0166	CbGeAlD
Liotrix—Wheezing—Cisplatin—esophageal cancer	0.000861	0.00881	CcSEcCtD
Liotrix—SLCO1A2—digestive system—esophageal cancer	0.000853	0.0162	CbGeAlD
Liotrix—Body temperature increased—Carboplatin—esophageal cancer	0.000852	0.00872	CcSEcCtD
Liotrix—SLCO1C1—lymph node—esophageal cancer	0.000849	0.0161	CbGeAlD
Liotrix—Fluid retention—Cisplatin—esophageal cancer	0.000842	0.00861	CcSEcCtD
Liotrix—Coagulopathy—Capecitabine—esophageal cancer	0.000839	0.00859	CcSEcCtD
Liotrix—Tingling sensation—Capecitabine—esophageal cancer	0.000813	0.00832	CcSEcCtD
Liotrix—Phlebitis—Cisplatin—esophageal cancer	0.000747	0.00764	CcSEcCtD
Liotrix—Cellulitis—Capecitabine—esophageal cancer	0.000719	0.00735	CcSEcCtD
Liotrix—Hypocalcaemia—Capecitabine—esophageal cancer	0.000714	0.0073	CcSEcCtD
Liotrix—SLCO1A2—lung—esophageal cancer	0.000712	0.0135	CbGeAlD
Liotrix—Cardiac failure congestive—Cisplatin—esophageal cancer	0.00071	0.00726	CcSEcCtD
Liotrix—Renal failure acute—Cisplatin—esophageal cancer	0.000697	0.00713	CcSEcCtD
Liotrix—Ulcer—Capecitabine—esophageal cancer	0.000691	0.00707	CcSEcCtD
Liotrix—Cyanosis—Methotrexate—esophageal cancer	0.000687	0.00703	CcSEcCtD
Liotrix—SLCO4A1—lymph node—esophageal cancer	0.00068	0.0129	CbGeAlD
Liotrix—Cerebrovascular accident—Cisplatin—esophageal cancer	0.000657	0.00672	CcSEcCtD
Liotrix—Fluid retention—Capecitabine—esophageal cancer	0.00062	0.00635	CcSEcCtD
Liotrix—Necrosis—Methotrexate—esophageal cancer	0.00062	0.00634	CcSEcCtD
Liotrix—Abscess—Methotrexate—esophageal cancer	0.000615	0.00629	CcSEcCtD
Liotrix—Irritability—Cisplatin—esophageal cancer	0.000614	0.00628	CcSEcCtD
Liotrix—Blood creatinine increased—Cisplatin—esophageal cancer	0.000603	0.00617	CcSEcCtD
Liotrix—Dehydration—Cisplatin—esophageal cancer	0.000598	0.00612	CcSEcCtD
Liotrix—SLC16A10—lymph node—esophageal cancer	0.000597	0.0113	CbGeAlD
Liotrix—Hypokalaemia—Cisplatin—esophageal cancer	0.000586	0.00599	CcSEcCtD
Liotrix—Sepsis—Capecitabine—esophageal cancer	0.000567	0.0058	CcSEcCtD
Liotrix—Extravasation—Methotrexate—esophageal cancer	0.000558	0.00571	CcSEcCtD
Liotrix—Phlebitis—Capecitabine—esophageal cancer	0.000551	0.00563	CcSEcCtD
Liotrix—Sweating increased—Cisplatin—esophageal cancer	0.000542	0.00554	CcSEcCtD
Liotrix—Swelling—Capecitabine—esophageal cancer	0.000538	0.0055	CcSEcCtD
Liotrix—Oliguria—Methotrexate—esophageal cancer	0.000528	0.0054	CcSEcCtD
Liotrix—Ulcer—Methotrexate—esophageal cancer	0.000514	0.00526	CcSEcCtD
Liotrix—Renal failure acute—Capecitabine—esophageal cancer	0.000514	0.00526	CcSEcCtD
Liotrix—Increased appetite—Capecitabine—esophageal cancer	0.000505	0.00517	CcSEcCtD
Liotrix—Renal impairment—Capecitabine—esophageal cancer	0.000498	0.0051	CcSEcCtD
Liotrix—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000489	0.005	CcSEcCtD
Liotrix—Renal failure—Cisplatin—esophageal cancer	0.000488	0.00499	CcSEcCtD
Liotrix—Myocardial infarction—Cisplatin—esophageal cancer	0.000486	0.00497	CcSEcCtD
Liotrix—Cardiac failure—Capecitabine—esophageal cancer	0.000486	0.00497	CcSEcCtD
Liotrix—ALB—lymph node—esophageal cancer	0.000484	0.0092	CbGeAlD
Liotrix—Cerebrovascular accident—Capecitabine—esophageal cancer	0.000484	0.00495	CcSEcCtD
Liotrix—Irritability—Capecitabine—esophageal cancer	0.000453	0.00463	CcSEcCtD
Liotrix—Cardiac arrest—Capecitabine—esophageal cancer	0.000451	0.00462	CcSEcCtD
Liotrix—Mood swings—Capecitabine—esophageal cancer	0.000449	0.0046	CcSEcCtD
Liotrix—Coma—Methotrexate—esophageal cancer	0.000445	0.00455	CcSEcCtD
Liotrix—Blood creatinine increased—Capecitabine—esophageal cancer	0.000444	0.00455	CcSEcCtD
Liotrix—Dehydration—Capecitabine—esophageal cancer	0.000441	0.00451	CcSEcCtD
Liotrix—Hypokalaemia—Capecitabine—esophageal cancer	0.000432	0.00442	CcSEcCtD
Liotrix—Sepsis—Methotrexate—esophageal cancer	0.000422	0.00432	CcSEcCtD
Liotrix—Muscular weakness—Capecitabine—esophageal cancer	0.000418	0.00428	CcSEcCtD
Liotrix—Flushing—Cisplatin—esophageal cancer	0.000413	0.00423	CcSEcCtD
Liotrix—Abdominal distension—Capecitabine—esophageal cancer	0.000413	0.00422	CcSEcCtD
Liotrix—Dysphagia—Capecitabine—esophageal cancer	0.00041	0.0042	CcSEcCtD
Liotrix—Bronchospasm—Capecitabine—esophageal cancer	0.000403	0.00413	CcSEcCtD
Liotrix—Angina pectoris—Capecitabine—esophageal cancer	0.000399	0.00409	CcSEcCtD
Liotrix—Sweating increased—Capecitabine—esophageal cancer	0.000399	0.00409	CcSEcCtD
Liotrix—Arrhythmia—Cisplatin—esophageal cancer	0.000398	0.00407	CcSEcCtD
Liotrix—Bronchitis—Capecitabine—esophageal cancer	0.000394	0.00403	CcSEcCtD
Liotrix—Alopecia—Cisplatin—esophageal cancer	0.000393	0.00403	CcSEcCtD
Liotrix—Renal failure acute—Methotrexate—esophageal cancer	0.000383	0.00391	CcSEcCtD
Liotrix—Flatulence—Cisplatin—esophageal cancer	0.000382	0.00391	CcSEcCtD
Liotrix—ABCB1—epithelium—esophageal cancer	0.000376	0.00714	CbGeAlD
Liotrix—Weight decreased—Capecitabine—esophageal cancer	0.000371	0.0038	CcSEcCtD
Liotrix—Vision blurred—Cisplatin—esophageal cancer	0.000365	0.00374	CcSEcCtD
Liotrix—Tremor—Cisplatin—esophageal cancer	0.000363	0.00372	CcSEcCtD
Liotrix—Acute coronary syndrome—Capecitabine—esophageal cancer	0.00036	0.00369	CcSEcCtD
Liotrix—Cerebrovascular accident—Methotrexate—esophageal cancer	0.00036	0.00369	CcSEcCtD
Liotrix—Renal failure—Capecitabine—esophageal cancer	0.000359	0.00368	CcSEcCtD
Liotrix—Myocardial infarction—Capecitabine—esophageal cancer	0.000358	0.00367	CcSEcCtD
Liotrix—Irritability—Methotrexate—esophageal cancer	0.000337	0.00345	CcSEcCtD
Liotrix—Convulsion—Cisplatin—esophageal cancer	0.000336	0.00344	CcSEcCtD
Liotrix—Mood swings—Methotrexate—esophageal cancer	0.000335	0.00342	CcSEcCtD
Liotrix—ABCB1—trachea—esophageal cancer	0.000332	0.00631	CbGeAlD
Liotrix—Anxiety—Cisplatin—esophageal cancer	0.000329	0.00336	CcSEcCtD
Liotrix—Hypoaesthesia—Capecitabine—esophageal cancer	0.000327	0.00334	CcSEcCtD
Liotrix—Levothyroxine—ABCB1—esophageal cancer	0.000321	0.584	CrCbGaD
Liotrix—Anaphylactic shock—Cisplatin—esophageal cancer	0.000316	0.00324	CcSEcCtD
Liotrix—Oedema—Cisplatin—esophageal cancer	0.000316	0.00324	CcSEcCtD
Liotrix—Infection—Cisplatin—esophageal cancer	0.000314	0.00322	CcSEcCtD
Liotrix—Tachycardia—Cisplatin—esophageal cancer	0.000309	0.00316	CcSEcCtD
Liotrix—Hyperhidrosis—Cisplatin—esophageal cancer	0.000306	0.00313	CcSEcCtD
Liotrix—Flushing—Capecitabine—esophageal cancer	0.000305	0.00312	CcSEcCtD
Liotrix—Anorexia—Cisplatin—esophageal cancer	0.000302	0.00308	CcSEcCtD
Liotrix—Hypotension—Cisplatin—esophageal cancer	0.000296	0.00302	CcSEcCtD
Liotrix—Arrhythmia—Capecitabine—esophageal cancer	0.000293	0.003	CcSEcCtD
Liotrix—Alopecia—Capecitabine—esophageal cancer	0.00029	0.00297	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000288	0.00295	CcSEcCtD
Liotrix—ABCB1—digestive system—esophageal cancer	0.000286	0.00543	CbGeAlD
Liotrix—Paraesthesia—Cisplatin—esophageal cancer	0.000284	0.00291	CcSEcCtD
Liotrix—Dyspnoea—Cisplatin—esophageal cancer	0.000282	0.00289	CcSEcCtD
Liotrix—Flatulence—Capecitabine—esophageal cancer	0.000282	0.00288	CcSEcCtD
Liotrix—Dysgeusia—Capecitabine—esophageal cancer	0.00028	0.00286	CcSEcCtD
Liotrix—Decreased appetite—Cisplatin—esophageal cancer	0.000275	0.00281	CcSEcCtD
Liotrix—Vision blurred—Capecitabine—esophageal cancer	0.000269	0.00275	CcSEcCtD
Liotrix—Tremor—Capecitabine—esophageal cancer	0.000268	0.00274	CcSEcCtD
Liotrix—Renal failure—Methotrexate—esophageal cancer	0.000268	0.00274	CcSEcCtD
Liotrix—Sweating—Methotrexate—esophageal cancer	0.000261	0.00267	CcSEcCtD
Liotrix—Feeling abnormal—Cisplatin—esophageal cancer	0.000261	0.00267	CcSEcCtD
Liotrix—Syncope—Capecitabine—esophageal cancer	0.000256	0.00262	CcSEcCtD
Liotrix—Palpitations—Capecitabine—esophageal cancer	0.000252	0.00258	CcSEcCtD
Liotrix—Loss of consciousness—Capecitabine—esophageal cancer	0.000251	0.00257	CcSEcCtD
Liotrix—Body temperature increased—Cisplatin—esophageal cancer	0.00025	0.00256	CcSEcCtD
Liotrix—Hypertension—Capecitabine—esophageal cancer	0.000247	0.00252	CcSEcCtD
Liotrix—Arthralgia—Capecitabine—esophageal cancer	0.000243	0.00249	CcSEcCtD
Liotrix—Chest pain—Capecitabine—esophageal cancer	0.000243	0.00249	CcSEcCtD
Liotrix—Anxiety—Capecitabine—esophageal cancer	0.000242	0.00248	CcSEcCtD
Liotrix—ABCB1—lung—esophageal cancer	0.000239	0.00453	CbGeAlD
Liotrix—Confusional state—Capecitabine—esophageal cancer	0.000235	0.00241	CcSEcCtD
Liotrix—Oedema—Capecitabine—esophageal cancer	0.000233	0.00239	CcSEcCtD
Liotrix—Hypersensitivity—Cisplatin—esophageal cancer	0.000233	0.00238	CcSEcCtD
Liotrix—Infection—Capecitabine—esophageal cancer	0.000232	0.00237	CcSEcCtD
Liotrix—Shock—Capecitabine—esophageal cancer	0.000229	0.00235	CcSEcCtD
Liotrix—Liothyronine—ABCB1—esophageal cancer	0.000229	0.416	CrCbGaD
Liotrix—Tachycardia—Capecitabine—esophageal cancer	0.000228	0.00233	CcSEcCtD
Liotrix—Asthenia—Cisplatin—esophageal cancer	0.000227	0.00232	CcSEcCtD
Liotrix—Hyperhidrosis—Capecitabine—esophageal cancer	0.000225	0.00231	CcSEcCtD
Liotrix—Anorexia—Capecitabine—esophageal cancer	0.000222	0.00227	CcSEcCtD
Liotrix—Hypotension—Capecitabine—esophageal cancer	0.000218	0.00223	CcSEcCtD
Liotrix—Diarrhoea—Cisplatin—esophageal cancer	0.000216	0.00221	CcSEcCtD
Liotrix—Alopecia—Methotrexate—esophageal cancer	0.000216	0.00221	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000212	0.00217	CcSEcCtD
Liotrix—Insomnia—Capecitabine—esophageal cancer	0.000211	0.00216	CcSEcCtD
Liotrix—Paraesthesia—Capecitabine—esophageal cancer	0.000209	0.00214	CcSEcCtD
Liotrix—Dysgeusia—Methotrexate—esophageal cancer	0.000208	0.00213	CcSEcCtD
Liotrix—Dyspnoea—Capecitabine—esophageal cancer	0.000208	0.00213	CcSEcCtD
Liotrix—Decreased appetite—Capecitabine—esophageal cancer	0.000203	0.00207	CcSEcCtD
Liotrix—Vomiting—Cisplatin—esophageal cancer	0.000201	0.00206	CcSEcCtD
Liotrix—Fatigue—Capecitabine—esophageal cancer	0.000201	0.00206	CcSEcCtD
Liotrix—Vision blurred—Methotrexate—esophageal cancer	0.0002	0.00205	CcSEcCtD
Liotrix—Rash—Cisplatin—esophageal cancer	0.000199	0.00204	CcSEcCtD
Liotrix—Constipation—Capecitabine—esophageal cancer	0.000199	0.00204	CcSEcCtD
Liotrix—Dermatitis—Cisplatin—esophageal cancer	0.000199	0.00204	CcSEcCtD
Liotrix—Feeling abnormal—Capecitabine—esophageal cancer	0.000192	0.00197	CcSEcCtD
Liotrix—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000191	0.00195	CcSEcCtD
Liotrix—Nausea—Cisplatin—esophageal cancer	0.000188	0.00192	CcSEcCtD
Liotrix—Urticaria—Capecitabine—esophageal cancer	0.000185	0.0019	CcSEcCtD
Liotrix—Abdominal pain—Capecitabine—esophageal cancer	0.000184	0.00189	CcSEcCtD
Liotrix—Body temperature increased—Capecitabine—esophageal cancer	0.000184	0.00189	CcSEcCtD
Liotrix—Convulsion—Methotrexate—esophageal cancer	0.000184	0.00189	CcSEcCtD
Liotrix—Chest pain—Methotrexate—esophageal cancer	0.000181	0.00185	CcSEcCtD
Liotrix—Arthralgia—Methotrexate—esophageal cancer	0.000181	0.00185	CcSEcCtD
Liotrix—Confusional state—Methotrexate—esophageal cancer	0.000175	0.00179	CcSEcCtD
Liotrix—Anaphylactic shock—Methotrexate—esophageal cancer	0.000174	0.00178	CcSEcCtD
Liotrix—Infection—Methotrexate—esophageal cancer	0.000172	0.00176	CcSEcCtD
Liotrix—Hypersensitivity—Capecitabine—esophageal cancer	0.000172	0.00176	CcSEcCtD
Liotrix—Hyperhidrosis—Methotrexate—esophageal cancer	0.000168	0.00172	CcSEcCtD
Liotrix—Asthenia—Capecitabine—esophageal cancer	0.000167	0.00171	CcSEcCtD
Liotrix—Anorexia—Methotrexate—esophageal cancer	0.000165	0.00169	CcSEcCtD
Liotrix—Pruritus—Capecitabine—esophageal cancer	0.000165	0.00169	CcSEcCtD
Liotrix—ABCB1—lymph node—esophageal cancer	0.000163	0.0031	CbGeAlD
Liotrix—Hypotension—Methotrexate—esophageal cancer	0.000162	0.00166	CcSEcCtD
Liotrix—Diarrhoea—Capecitabine—esophageal cancer	0.00016	0.00163	CcSEcCtD
Liotrix—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000158	0.00162	CcSEcCtD
Liotrix—Insomnia—Methotrexate—esophageal cancer	0.000157	0.00161	CcSEcCtD
Liotrix—Paraesthesia—Methotrexate—esophageal cancer	0.000156	0.00159	CcSEcCtD
Liotrix—Dyspnoea—Methotrexate—esophageal cancer	0.000155	0.00158	CcSEcCtD
Liotrix—Dizziness—Capecitabine—esophageal cancer	0.000154	0.00158	CcSEcCtD
Liotrix—Decreased appetite—Methotrexate—esophageal cancer	0.000151	0.00154	CcSEcCtD
Liotrix—Fatigue—Methotrexate—esophageal cancer	0.00015	0.00153	CcSEcCtD
Liotrix—Vomiting—Capecitabine—esophageal cancer	0.000148	0.00152	CcSEcCtD
Liotrix—Rash—Capecitabine—esophageal cancer	0.000147	0.0015	CcSEcCtD
Liotrix—Dermatitis—Capecitabine—esophageal cancer	0.000147	0.0015	CcSEcCtD
Liotrix—Headache—Capecitabine—esophageal cancer	0.000146	0.00149	CcSEcCtD
Liotrix—Feeling abnormal—Methotrexate—esophageal cancer	0.000143	0.00146	CcSEcCtD
Liotrix—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000142	0.00145	CcSEcCtD
Liotrix—Nausea—Capecitabine—esophageal cancer	0.000138	0.00142	CcSEcCtD
Liotrix—Urticaria—Methotrexate—esophageal cancer	0.000138	0.00141	CcSEcCtD
Liotrix—Body temperature increased—Methotrexate—esophageal cancer	0.000137	0.0014	CcSEcCtD
Liotrix—Abdominal pain—Methotrexate—esophageal cancer	0.000137	0.0014	CcSEcCtD
Liotrix—Hypersensitivity—Methotrexate—esophageal cancer	0.000128	0.00131	CcSEcCtD
Liotrix—Asthenia—Methotrexate—esophageal cancer	0.000125	0.00127	CcSEcCtD
Liotrix—Pruritus—Methotrexate—esophageal cancer	0.000123	0.00126	CcSEcCtD
Liotrix—Diarrhoea—Methotrexate—esophageal cancer	0.000119	0.00122	CcSEcCtD
Liotrix—Dizziness—Methotrexate—esophageal cancer	0.000115	0.00117	CcSEcCtD
Liotrix—Vomiting—Methotrexate—esophageal cancer	0.00011	0.00113	CcSEcCtD
Liotrix—Rash—Methotrexate—esophageal cancer	0.000109	0.00112	CcSEcCtD
Liotrix—Dermatitis—Methotrexate—esophageal cancer	0.000109	0.00112	CcSEcCtD
Liotrix—Headache—Methotrexate—esophageal cancer	0.000109	0.00111	CcSEcCtD
Liotrix—Nausea—Methotrexate—esophageal cancer	0.000103	0.00105	CcSEcCtD
Liotrix—SLCO1B1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	3.18e-05	0.00033	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—ALDOB—esophageal cancer	3.15e-05	0.000327	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—TYMP—esophageal cancer	3.11e-05	0.000323	CbGpPWpGaD
Liotrix—TTR—Disease—NOS2—esophageal cancer	3.05e-05	0.000317	CbGpPWpGaD
Liotrix—SLCO1B1—Transmembrane transport of small molecules—ABCB1—esophageal cancer	3.05e-05	0.000317	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—ENO1—esophageal cancer	3.04e-05	0.000315	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PTGS1—esophageal cancer	3.04e-05	0.000315	CbGpPWpGaD
Liotrix—SLCO1B3—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.04e-05	0.000315	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—TGFBR2—esophageal cancer	3.03e-05	0.000315	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—GAPDH—esophageal cancer	3.03e-05	0.000315	CbGpPWpGaD
Liotrix—TTR—Disease—NOTCH1—esophageal cancer	3.02e-05	0.000314	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CYP26A1—esophageal cancer	3.02e-05	0.000314	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—CRABP1—esophageal cancer	3e-05	0.000312	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PSME2—esophageal cancer	2.99e-05	0.000311	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PSME1—esophageal cancer	2.99e-05	0.000311	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—GNG7—esophageal cancer	2.98e-05	0.00031	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—SLC52A3—esophageal cancer	2.95e-05	0.000306	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—BLVRB—esophageal cancer	2.95e-05	0.000306	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—ALOX15—esophageal cancer	2.94e-05	0.000306	CbGpPWpGaD
Liotrix—ALB—Metabolism—SLC52A3—esophageal cancer	2.93e-05	0.000304	CbGpPWpGaD
Liotrix—ALB—Metabolism—BLVRB—esophageal cancer	2.93e-05	0.000304	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	2.88e-05	0.000299	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—SMAD4—esophageal cancer	2.87e-05	0.000298	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—GNG7—esophageal cancer	2.86e-05	0.000297	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—TPI1—esophageal cancer	2.81e-05	0.000292	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GSTO1—esophageal cancer	2.81e-05	0.000292	CbGpPWpGaD
Liotrix—ALB—Hemostasis—HSPA5—esophageal cancer	2.81e-05	0.000292	CbGpPWpGaD
Liotrix—TTR—Disease—CREBBP—esophageal cancer	2.74e-05	0.000285	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—ALDOB—esophageal cancer	2.69e-05	0.00028	CbGpPWpGaD
Liotrix—SLC22A8—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.69e-05	0.000279	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—ALDH2—esophageal cancer	2.68e-05	0.000278	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	2.63e-05	0.000274	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	2.62e-05	0.000272	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.61e-05	0.000271	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	2.61e-05	0.000271	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GAPDH—esophageal cancer	2.59e-05	0.000269	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—CYP1B1—esophageal cancer	2.58e-05	0.000268	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	2.58e-05	0.000268	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	2.57e-05	0.000267	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CRABP1—esophageal cancer	2.57e-05	0.000267	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.57e-05	0.000267	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—SLC52A3—esophageal cancer	2.57e-05	0.000267	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—BLVRB—esophageal cancer	2.57e-05	0.000267	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—GSTT1—esophageal cancer	2.55e-05	0.000265	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—CYP2A6—esophageal cancer	2.52e-05	0.000261	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.51e-05	0.00026	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CA1—esophageal cancer	2.5e-05	0.00026	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—SLC10A2—esophageal cancer	2.5e-05	0.00026	CbGpPWpGaD
Liotrix—ALB—Metabolism—CA1—esophageal cancer	2.49e-05	0.000259	CbGpPWpGaD
Liotrix—ALB—Metabolism—SLC10A2—esophageal cancer	2.49e-05	0.000259	CbGpPWpGaD
Liotrix—THRA—Gene Expression—MYC—esophageal cancer	2.46e-05	0.000255	CbGpPWpGaD
Liotrix—THRB—Gene Expression—MYC—esophageal cancer	2.46e-05	0.000255	CbGpPWpGaD
Liotrix—TTR—Disease—NOS3—esophageal cancer	2.45e-05	0.000255	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GNG7—esophageal cancer	2.44e-05	0.000254	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—CYP19A1—esophageal cancer	2.43e-05	0.000252	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PTGS1—esophageal cancer	2.39e-05	0.000248	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—ENO1—esophageal cancer	2.39e-05	0.000248	CbGpPWpGaD
Liotrix—SLCO1A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.38e-05	0.000248	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PSME2—esophageal cancer	2.35e-05	0.000244	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PSME1—esophageal cancer	2.35e-05	0.000244	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—HIF1A—esophageal cancer	2.35e-05	0.000244	CbGpPWpGaD
Liotrix—TTR—Disease—ERBB2—esophageal cancer	2.3e-05	0.000238	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CA2—esophageal cancer	2.29e-05	0.000238	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—ALDH2—esophageal cancer	2.29e-05	0.000238	CbGpPWpGaD
Liotrix—ALB—Metabolism—CA2—esophageal cancer	2.28e-05	0.000237	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—CREBBP—esophageal cancer	2.27e-05	0.000236	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—KDR—esophageal cancer	2.25e-05	0.000233	CbGpPWpGaD
Liotrix—TTR—Disease—PTGS2—esophageal cancer	2.24e-05	0.000233	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.24e-05	0.000233	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.23e-05	0.000231	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	2.22e-05	0.00023	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—HMOX1—esophageal cancer	2.22e-05	0.00023	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CA1—esophageal cancer	2.18e-05	0.000227	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—SLC10A2—esophageal cancer	2.18e-05	0.000227	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—GSTT1—esophageal cancer	2.18e-05	0.000226	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.17e-05	0.000226	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	2.15e-05	0.000224	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CYP2A6—esophageal cancer	2.15e-05	0.000224	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.14e-05	0.000223	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PLCE1—esophageal cancer	2.13e-05	0.000221	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ADH7—esophageal cancer	2.13e-05	0.000221	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—ABCB1—esophageal cancer	2.13e-05	0.000221	CbGpPWpGaD
Liotrix—ALB—Metabolism—PLCE1—esophageal cancer	2.12e-05	0.00022	CbGpPWpGaD
Liotrix—ALB—Metabolism—ADH7—esophageal cancer	2.12e-05	0.00022	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—NOTCH1—esophageal cancer	2.12e-05	0.00022	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	2.11e-05	0.000219	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.11e-05	0.000219	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.09e-05	0.000217	CbGpPWpGaD
Liotrix—ALB—Hemostasis—ABL1—esophageal cancer	2.08e-05	0.000216	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.05e-05	0.000213	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—ENO1—esophageal cancer	2.04e-05	0.000212	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PTGS1—esophageal cancer	2.04e-05	0.000212	CbGpPWpGaD
Liotrix—SLCO1B1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	2.04e-05	0.000212	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—NOS3—esophageal cancer	2.03e-05	0.000211	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—CYP1B1—esophageal cancer	2.03e-05	0.000211	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PSME2—esophageal cancer	2.01e-05	0.000209	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PSME1—esophageal cancer	2.01e-05	0.000209	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CA2—esophageal cancer	2e-05	0.000207	CbGpPWpGaD
Liotrix—TTR—Disease—CDKN1A—esophageal cancer	1.96e-05	0.000204	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CREBBP—esophageal cancer	1.92e-05	0.000199	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—CYP19A1—esophageal cancer	1.91e-05	0.000198	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	1.9e-05	0.000198	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ADH1B—esophageal cancer	1.87e-05	0.000194	CbGpPWpGaD
Liotrix—TTR—Disease—EP300—esophageal cancer	1.87e-05	0.000194	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PTGS2—esophageal cancer	1.86e-05	0.000193	CbGpPWpGaD
Liotrix—ALB—Metabolism—ADH1B—esophageal cancer	1.86e-05	0.000193	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ADH7—esophageal cancer	1.86e-05	0.000193	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PLCE1—esophageal cancer	1.86e-05	0.000193	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	1.84e-05	0.000191	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.82e-05	0.000189	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—TYMP—esophageal cancer	1.78e-05	0.000185	CbGpPWpGaD
Liotrix—ALB—Metabolism—TYMP—esophageal cancer	1.77e-05	0.000184	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.76e-05	0.000182	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	1.75e-05	0.000182	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—ABCB1—esophageal cancer	1.74e-05	0.000181	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—HMOX1—esophageal cancer	1.74e-05	0.000181	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP26A1—esophageal cancer	1.74e-05	0.00018	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CYP1B1—esophageal cancer	1.74e-05	0.00018	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP26A1—esophageal cancer	1.73e-05	0.000179	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—NOS3—esophageal cancer	1.72e-05	0.000179	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.71e-05	0.000177	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ALOX15—esophageal cancer	1.69e-05	0.000176	CbGpPWpGaD
Liotrix—ALB—Metabolism—ALOX15—esophageal cancer	1.68e-05	0.000175	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—ABCB1—esophageal cancer	1.67e-05	0.000174	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CYP19A1—esophageal cancer	1.63e-05	0.000169	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ADH1B—esophageal cancer	1.63e-05	0.000169	CbGpPWpGaD
Liotrix—TTR—Disease—MYC—esophageal cancer	1.63e-05	0.000169	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GSTO1—esophageal cancer	1.61e-05	0.000168	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—TPI1—esophageal cancer	1.61e-05	0.000168	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.61e-05	0.000167	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—ERBB2—esophageal cancer	1.61e-05	0.000167	CbGpPWpGaD
Liotrix—ALB—Metabolism—GSTO1—esophageal cancer	1.6e-05	0.000167	CbGpPWpGaD
Liotrix—ALB—Metabolism—TPI1—esophageal cancer	1.6e-05	0.000167	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	1.59e-05	0.000165	CbGpPWpGaD
Liotrix—TTR—Disease—EGFR—esophageal cancer	1.59e-05	0.000165	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—TYMP—esophageal cancer	1.55e-05	0.000161	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ALDOB—esophageal cancer	1.55e-05	0.000161	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—EP300—esophageal cancer	1.55e-05	0.000161	CbGpPWpGaD
Liotrix—ALB—Metabolism—ALDOB—esophageal cancer	1.54e-05	0.00016	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	1.53e-05	0.000158	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP26A1—esophageal cancer	1.51e-05	0.000157	CbGpPWpGaD
Liotrix—ALB—Hemostasis—NOS2—esophageal cancer	1.5e-05	0.000156	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	1.49e-05	0.000155	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GAPDH—esophageal cancer	1.49e-05	0.000155	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—HMOX1—esophageal cancer	1.49e-05	0.000155	CbGpPWpGaD
Liotrix—ALB—Metabolism—GAPDH—esophageal cancer	1.48e-05	0.000154	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CRABP1—esophageal cancer	1.48e-05	0.000153	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ALOX15—esophageal cancer	1.47e-05	0.000153	CbGpPWpGaD
Liotrix—ALB—Metabolism—CRABP1—esophageal cancer	1.47e-05	0.000152	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.46e-05	0.000152	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—ABCB1—esophageal cancer	1.43e-05	0.000148	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—CREBBP—esophageal cancer	1.42e-05	0.000148	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CCND1—esophageal cancer	1.42e-05	0.000148	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GSTO1—esophageal cancer	1.41e-05	0.000146	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—TPI1—esophageal cancer	1.41e-05	0.000146	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GNG7—esophageal cancer	1.4e-05	0.000146	CbGpPWpGaD
Liotrix—ALB—Metabolism—GNG7—esophageal cancer	1.4e-05	0.000145	CbGpPWpGaD
Liotrix—TTR—Disease—PIK3CA—esophageal cancer	1.38e-05	0.000143	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—CDKN1A—esophageal cancer	1.37e-05	0.000143	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ALDOB—esophageal cancer	1.35e-05	0.00014	CbGpPWpGaD
Liotrix—ALB—Hemostasis—CREBBP—esophageal cancer	1.35e-05	0.00014	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ALDH2—esophageal cancer	1.32e-05	0.000137	CbGpPWpGaD
Liotrix—ALB—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	1.32e-05	0.000137	CbGpPWpGaD
Liotrix—ALB—Metabolism—ALDH2—esophageal cancer	1.31e-05	0.000136	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—EP300—esophageal cancer	1.31e-05	0.000136	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GAPDH—esophageal cancer	1.3e-05	0.000135	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	1.3e-05	0.000135	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CRABP1—esophageal cancer	1.29e-05	0.000134	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—NOS3—esophageal cancer	1.27e-05	0.000132	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.26e-05	0.000131	CbGpPWpGaD
Liotrix—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.25e-05	0.00013	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—GSTT1—esophageal cancer	1.25e-05	0.00013	CbGpPWpGaD
Liotrix—ALB—Metabolism—GSTT1—esophageal cancer	1.24e-05	0.000129	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP2A6—esophageal cancer	1.24e-05	0.000128	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.23e-05	0.000128	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP2A6—esophageal cancer	1.23e-05	0.000128	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.23e-05	0.000127	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GNG7—esophageal cancer	1.22e-05	0.000127	CbGpPWpGaD
Liotrix—ALB—Hemostasis—NOS3—esophageal cancer	1.21e-05	0.000125	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ENO1—esophageal cancer	1.17e-05	0.000122	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PTGS1—esophageal cancer	1.17e-05	0.000122	CbGpPWpGaD
Liotrix—ALB—Metabolism—ENO1—esophageal cancer	1.17e-05	0.000121	CbGpPWpGaD
Liotrix—ALB—Metabolism—PTGS1—esophageal cancer	1.17e-05	0.000121	CbGpPWpGaD
Liotrix—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.17e-05	0.000121	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PTGS2—esophageal cancer	1.16e-05	0.000121	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PSME2—esophageal cancer	1.16e-05	0.00012	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PSME1—esophageal cancer	1.16e-05	0.00012	CbGpPWpGaD
Liotrix—ALB—Metabolism—PSME1—esophageal cancer	1.15e-05	0.000119	CbGpPWpGaD
Liotrix—ALB—Metabolism—PSME2—esophageal cancer	1.15e-05	0.000119	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ALDH2—esophageal cancer	1.15e-05	0.000119	CbGpPWpGaD
Liotrix—SLC10A1—Metabolism—PIK3CA—esophageal cancer	1.14e-05	0.000119	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—MYC—esophageal cancer	1.14e-05	0.000118	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—CREBBP—esophageal cancer	1.12e-05	0.000116	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—EGFR—esophageal cancer	1.11e-05	0.000116	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—GSTT1—esophageal cancer	1.09e-05	0.000113	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.08e-05	0.000112	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP2A6—esophageal cancer	1.08e-05	0.000112	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—ENO1—esophageal cancer	1.02e-05	0.000106	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PTGS1—esophageal cancer	1.02e-05	0.000106	CbGpPWpGaD
Liotrix—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.02e-05	0.000106	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.01e-05	0.000105	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PSME1—esophageal cancer	1.01e-05	0.000105	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PSME2—esophageal cancer	1.01e-05	0.000105	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1e-05	0.000104	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—NOS3—esophageal cancer	1e-05	0.000104	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP1B1—esophageal cancer	9.97e-06	0.000104	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP1B1—esophageal cancer	9.92e-06	0.000103	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—EP300—esophageal cancer	9.68e-06	0.000101	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—PIK3CA—esophageal cancer	9.67e-06	0.0001	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—CREBBP—esophageal cancer	9.55e-06	9.92e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CYP19A1—esophageal cancer	9.38e-06	9.74e-05	CbGpPWpGaD
Liotrix—TTR—Signaling Pathways—TP53—esophageal cancer	9.36e-06	9.72e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CYP19A1—esophageal cancer	9.32e-06	9.68e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—EP300—esophageal cancer	9.17e-06	9.52e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PTGS2—esophageal cancer	9.15e-06	9.5e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP1B1—esophageal cancer	8.69e-06	9.02e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—HMOX1—esophageal cancer	8.56e-06	8.89e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—NOS3—esophageal cancer	8.55e-06	8.88e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—HMOX1—esophageal cancer	8.51e-06	8.84e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8.39e-06	8.72e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	8.35e-06	8.67e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—ABCB1—esophageal cancer	8.21e-06	8.53e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CYP19A1—esophageal cancer	8.17e-06	8.48e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—ABCB1—esophageal cancer	8.16e-06	8.48e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PTGS2—esophageal cancer	7.82e-06	8.12e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—EP300—esophageal cancer	7.61e-06	7.9e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—HMOX1—esophageal cancer	7.45e-06	7.74e-05	CbGpPWpGaD
Liotrix—SLCO1B3—Metabolism—PIK3CA—esophageal cancer	7.16e-06	7.44e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—PIK3CA—esophageal cancer	6.78e-06	7.04e-05	CbGpPWpGaD
Liotrix—ALB—Hemostasis—TP53—esophageal cancer	6.56e-06	6.81e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—EP300—esophageal cancer	6.5e-06	6.76e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.21e-06	6.45e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.17e-06	6.41e-05	CbGpPWpGaD
Liotrix—SLCO1A2—Metabolism—PIK3CA—esophageal cancer	5.63e-06	5.84e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—CREBBP—esophageal cancer	5.49e-06	5.7e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—CREBBP—esophageal cancer	5.46e-06	5.67e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—NOS3—esophageal cancer	4.91e-06	5.1e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—NOS3—esophageal cancer	4.89e-06	5.07e-05	CbGpPWpGaD
Liotrix—SLCO1B1—Metabolism—PIK3CA—esophageal cancer	4.81e-06	5e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—CREBBP—esophageal cancer	4.78e-06	4.97e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PTGS2—esophageal cancer	4.49e-06	4.67e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PTGS2—esophageal cancer	4.47e-06	4.64e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—NOS3—esophageal cancer	4.28e-06	4.45e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PTGS2—esophageal cancer	3.92e-06	4.07e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—EP300—esophageal cancer	3.74e-06	3.88e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—EP300—esophageal cancer	3.72e-06	3.86e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—EP300—esophageal cancer	3.26e-06	3.38e-05	CbGpPWpGaD
Liotrix—CYP2C8—Metabolism—PIK3CA—esophageal cancer	2.77e-06	2.87e-05	CbGpPWpGaD
Liotrix—ALB—Metabolism—PIK3CA—esophageal cancer	2.75e-06	2.86e-05	CbGpPWpGaD
Liotrix—ABCB1—Metabolism—PIK3CA—esophageal cancer	2.41e-06	2.5e-05	CbGpPWpGaD
